Venclose

SCOPE
Develop a state-of-the-art RF ablation system for venous disease treatment, including the generator, control box, software controls, catheter, and consumables.
OUTCOME
The device received 510(k) approval and entered the market in 2.5 years. Production was successfully transferred to a low-cost region and Venclose was acquired by BD.

Meet Our Team

Get in touch with us today to see how we can help you achieve your goals.